Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas

被引:97
作者
McKnight, Tracy R. [1 ]
Lamborn, Kathleen R. [1 ]
Love, Tonya D. [1 ]
Berger, Mitchel S. [1 ]
Chang, Susan [1 ]
Dillon, William P. [1 ]
Bollen, Andrew [1 ]
Nelson, Sarah J. [1 ]
机构
[1] Univ Calif San Francisco, Ctr Mol & Funct Imaging, San Francisco, CA 94107 USA
关键词
intratumoral heterogeneity; biopsy; magnetic resonance spectroscopy; MIB-1; index; TUNEL; glioma;
D O I
10.3171/jns.2007.106.4.660
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The accurate diagnosis of World Health Organization Grades II and III gliomas is crucial for the effective treatment of patients with such lesions. Increased cell density and mitotic activity are histological features that distinguish Grade III from Grade II gliomas. Because increased cellular proliferation and density both contribute to the in vivo magnetic resonance (MR) spectroscopic peak corresponding to choline-comaining compounds (Cho), the authors hypothesized that multivoxel MR spectroscopy might help identify the tumor regions with the most aggressive growth characteristics, which would be optimal locations for biopsy. They investigated the ability to use one or more MR spectroscopic parameters to predict the MIB-I cell proliferation index (PI), the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling cell death index (DI), the cell density, and the ratio of proliferation to cell death (PUDI) within different regions of the same tumor. Methods. Patients with presumed Grades II or III glioma underwent 3D MR spectroscopic imaging prior to surgery, and two or three regions within the tumor were targeted for biopsy retrieval based on their spectroscopic features. Biopsy specimens were extracted from the tumor during image-guided resection, and the PI, DI, and cell density were assessed in the specimens using immunohistochernical methods. Conclusions. The authors found that the relative levels of Cho and N-acetylaspartate (NAA) correlated with the cell density, PI, and PI/DI ratio within different regions of the same tumor and that the association held for the subpopulation of nonenhancing tumors. The association was stronger in tumors with large ranges of Cho/NAA values, irrespective of the presence of contrast enhancement. The findings demonstrate the validity of using MR spectroscopy to identify regions of aggressive growth in presumed Grade II or III gliomas that would be suitable targets for retrieving diagnostic biopsy specimens.
引用
收藏
页码:660 / 666
页数:7
相关论文
共 29 条
  • [1] Barbarella G, 1998, INT J ONCOL, V12, P461
  • [2] CBTRUS, 2002, STAT REP PRIM BRAIN
  • [3] Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: Semiquantitative and qualitative histopathological analyses of patients with untreated glioma
    Croteau, D
    Scarpace, L
    Hearshen, D
    Gutierrez, J
    Fisher, JL
    Rock, JP
    Mikkelsen, T
    [J]. NEUROSURGERY, 2001, 49 (04) : 823 - 829
  • [4] Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives
    Falini, A
    Calabrese, G
    Origgi, D
    Lipari, S
    Triulzi, F
    Losa, M
    Scotti, G
    [J]. JOURNAL OF NEUROLOGY, 1996, 243 (10) : 706 - 714
  • [5] In vivo proton magnetic resonance spectroscopy of brain tumors
    Fountas, KN
    Kapsalaki, EZ
    Gotsis, SD
    Kapsalakis, JZ
    Smisson, HF
    Johnston, KW
    Robinson, JS
    Papadakis, N
    [J]. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2000, 74 (02) : 83 - 94
  • [6] MAPPING OF BRAIN-TUMOR METABOLITES WITH PROTON MR SPECTROSCOPIC IMAGING - CLINICAL RELEVANCE
    FULHAM, MJ
    BIZZI, A
    DIETZ, MJ
    SHIH, HHL
    RAMAN, R
    SOBERING, GS
    FRANK, JA
    DWYER, AJ
    ALGER, JR
    DICHIRO, G
    [J]. RADIOLOGY, 1992, 185 (03) : 675 - 686
  • [7] Furuya S, 1997, NMR BIOMED, V10, P25, DOI 10.1002/(SICI)1099-1492(199701)10:1<25::AID-NBM445>3.0.CO
  • [8] 2-M
  • [9] Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma
    Gupta, RK
    Cloughesy, TF
    Sinha, U
    Garakian, J
    Lazareff, J
    Rubino, G
    Rubino, L
    Becker, DP
    Vinters, HV
    Alger, JR
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2000, 50 (03) : 215 - 226
  • [10] Hagberg G, 1998, NMR BIOMED, V11, P148, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<148::AID-NBM511>3.0.CO